Page last updated: 2024-08-21

canrenone and Liver Cirrhosis

canrenone has been researched along with Liver Cirrhosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caligiuri, A; De Franco, RM; Failli, P; Geerts, A; Gentilini, A; Gentilini, P; Marra, F; Mazzetti, L; Meucci, M; Pinzani, M; Romanelli, RG; Rombouts, K; Vanasia, M1
Barletta, G; Del Bene, R; Gentilini, P; La Villa, G; Laffi, G; Mazzocchi, V; Pantaleo, P; Romanelli, RG; Vizzutti, F1
Juhos, E; Radó, JP; Sawinsky, I2
Gentilini, P1
Andriulli, A; Armanini, D; Arrigoni, A; Buzzetti, G; Gindro, T; Karbowiak, I1

Trials

2 trial(s) available for canrenone and Liver Cirrhosis

ArticleYear
Cardiovascular effects of canrenone in patients with preascitic cirrhosis.
    Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:6

    Topics: Aged; Ascites; Blood Pressure; Body Weight; Canrenone; Female; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Plasma Volume; Sodium; Stroke Volume; Ventricular Function, Left

2002
Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapy.
    Digestion, 1989, Volume: 44, Issue:3

    Topics: Adult; Aged; Ascites; Canrenoic Acid; Canrenone; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Pregnadienes; Random Allocation; Receptors, Androgen; Recurrence; Spironolactone; Testosterone; Time Factors

1989

Other Studies

4 other study(ies) available for canrenone and Liver Cirrhosis

ArticleYear
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells.
    Gastroenterology, 2003, Volume: 124, Issue:2

    Topics: Aldosterone; Amiloride; Calcium; Canrenone; Cell Division; Cell Movement; Cells, Cultured; Extracellular Matrix Proteins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Guanidines; Humans; Hydrogen-Ion Concentration; Intracellular Membranes; Liver; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Phosphatidylinositol 3-Kinases; Phosphorylation; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Signal Transduction; Sodium-Hydrogen Exchangers; Sulfones; Thrombin

2003
Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1976, Volume: 8, Issue:3

    Topics: Amiloride; Canrenone; Humans; Kidney Tubules; Liver Cirrhosis; Loop of Henle; Male; Middle Aged; Potassium; Pregnadienes; Pyrazines; Sodium; Spironolactone; Triamterene

1976
Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis.
    International journal of clinical pharmacology and biopharmacy, 1976, Volume: 14, Issue:3

    Topics: Amiloride; Ascites; Canrenone; Diuresis; Diuretics; Drug Synergism; Drug Therapy, Combination; Humans; Liver Cirrhosis; Natriuresis; Potassium; Spironolactone; Triamterene

1976
Spironolactone and canrenoate: different antialdosteronic diuretic agents.
    Hepatology (Baltimore, Md.), 1991, Volume: 13, Issue:5

    Topics: Ascites; Canrenoic Acid; Canrenone; Humans; Liver Cirrhosis; Recurrence; Spironolactone

1991